Immunodeficiency
Anaphylaxis resources
Anaphylaxis resources
Action/treatment plans
Action/treatment plans
ASCIA 2020 Conference
ASCIA 2021 Conference
Locate a specialist
Locate a Specialist
Patient information
Patient information
Health professionals
Health professionals
ASCIA e-training courses
ASCIA e-training
Immunodeficiency
Immunodeficiency
Drug allergy
Drug allergy
Hay fever/asthma
Hay fever/asthma/sinusitis
Food allergy
Allergy and the skin
National Allergy Strategy

Go to website

Nip Allergies in the Bub

Go to website

Food Allergy Training

Go to website

ASCIA News

  • ASCIA COVID-19 Update
    24 March 2020: ASCIA COVID-19 website updates The ASCIA COVID-19 webpage www.allergy.org.au/members/covid-19 is reviewed on a daily basis and updated as required. The latest updates are as follows: The ASCIA 2020 Conference has been postponed to September 2021. This will be...
  • ASCIA Annual Conference postponed to September 2021
    23 March 2020: ASCIA has closely monitored the COVID-19 outbreak in relation to the ASCIA 2020 Conference, which was scheduled for the first week of September 2020 in Melbourne. Given that the situation has rapidly evolved in Australia and New Zealand, we have decided to pos...
  • ASCIA COVID-19 Update
    16 March 2020: In response to the COVID-19 infectious respiratory disease outbreak caused by the most recently discovered coronavirus, ASCIA has developed a number of resources, including a new open access ASCIA webpage dedicated to COVID-19 information. The situation regard...
  • ASCIA information about COVID-19
    12 March 2020: ASCIA has developed the following resources in response to the COVID-19 infectious respiratory disease outbreak caused by the most recently discovered coronavirus, which are available open access on the ASCIA COVID-19 webpage https://www.allergy.org.au/members...
  • Supply update - EpiPen® adrenaline (epinephrine) autoinjectors
    9 March 2020: Mylan Australia has advised that despite there being sufficient supply of EpiPen®. unprecedented, disproportionate demand has meant that some pharmacies are experiencing supply delays and are seeing stock outages at some wholesalers, To ensure equitable distrib...
  • Hymenoptera® venom product supply update
    9th March 2020: There is currently limited stock of Hymenoptera® Honey Bee venom in Australia and New Zealand. This is due to critical manufacturing issues at Jubilant HollisterStier LLC, which negatively impacts their ability to ship venoms outside of the USA in the short t...
  • Updated ASCIA OIT for food allergy information
    4 March 2020: Oral immunotherapy (OIT) is a potential treatment for food allergy. It involves giving gradually increasing amounts of food allergen under medical supervision and continued daily consumption of the food allergen. If the goal of desensitisation is reached, there...
  • Updated ASCIA HAE information
    1 March 2020: ASCIA has updated its information on hereditary angioedema (HAE), to be consistent with international guidelines and include new treatments, and the following resources are now available on the ASCIA website www.allergy.org.au/hp/papers/hereditary-angioedema Up...

  • Site updated: 31 Mar 2020


ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...

Join our mailing list here...

AIFA: Donate Now
AIFA: Donate Now

Go to website

National Allergy Strategy
National Allergy Strategy

Go to website

ASCIA: WAO Member
ASCIA: WAO Member

Go to website

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.